Johnson & Johnson offers to pay $5.5bn to settle baby powder lawsuits
Johnson & Johnson has proposed a $5.5 billion settlement to resolve approximately 76,000 lawsuits alleging that its talc-based baby powder products cause ovarian cancer. The company continues to deny the allegations but seeks to end the long-standing legal battle.
Why it matters
This settlement represents a major corporate legal resolution that impacts both consumer safety perceptions and the financial standing of a global healthcare giant.
Image source, Reuters By Osmond Chia Business reporter Published 28 July 2026, 02:24 BST Updated 02:53 BST Johnson & Johnson (J&J) has offered to pay as much as $5.5bn (£4.14bn) to resolve tens of thousands of lawsuits in the US alleging that its baby powder and other products containing talcum cause ovarian cancer.
The proposed landmark settlement aims to close a long-running legal battle that has weighed on the New Jersey-based healthcare giant for years.
J&J has denied that its talc-based products caused cancer and has changed the formula of its widely used baby powder.
Erik Haas, the firm's vice president of litigation said on Monday , external that the allegations are "meritless" and that J&J was willing to settle in order to finally resolve the matter.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in